Skip to main content

Advertisement

Log in

A need for biology-driven personalized radiotherapy in breast cancer

  • Brief Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jatoi I, Anderson WF, Jeong JH et al (2011) Breast cancer adjuvant therapy: time to consider its time-dependent effects. J Clin Oncol 29:2301–2304

    Article  PubMed  PubMed Central  Google Scholar 

  2. Tsoutsou PG, Vozenin MC, Durham AD et al (2017) How could breast cancer molecular features contribute to locoregional treatment decision making? Crit Rev Oncol Hematol 110:43–48

    Article  PubMed  Google Scholar 

  3. Kyndi M, Sørensen FB, Knudsen H, Danish Breast Cancer Cooperative Group et al (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish breast cancer cooperative group. J Clin Oncol 26:1419–1426

    Article  CAS  PubMed  Google Scholar 

  4. Sjöström M, Lundstedt D, Hartman L et al. (2017) Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the swedish breast cancer group 91 radiotherapy randomized clinical trial. J Clin Oncol

  5. Duru N, Fan M, Candas D et al (2012) HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clin Cancer Res 18:6634–6647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Panoff JE, Hurley J, Takita C et al (2011) Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat 128(3):899–906

    Article  CAS  PubMed  Google Scholar 

  7. Pietras RJ, Poen JC, Gallardo D et al (1999) Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res 59(6):1347–1355

    CAS  PubMed  Google Scholar 

  8. Poortmans PM, Collette S, Kirkove C, EORTC Radiation Oncology and Breast Cancer Groups et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327

    Article  CAS  PubMed  Google Scholar 

  9. Punglia RS, Morrow M, Winer EP, Harris JR (2007) Local therapy and survival in breast cancer. N Engl J Med 356:2399–2405

    Article  CAS  PubMed  Google Scholar 

  10. Karn T, Jiang T, Hatzis C et al. (2017) Association between genomic metrics and immune infiltration in triple-negative breast cancer. JAMA Oncol

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pelagia G. Tsoutsou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsoutsou, P.G., Durham, AD. & Vozenin, MC. A need for biology-driven personalized radiotherapy in breast cancer. Breast Cancer Res Treat 167, 603–604 (2018). https://doi.org/10.1007/s10549-017-4522-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-017-4522-z

Navigation